Hypervigilance to pain may predict the transition from subacute to chronic back pain: a longitudinal observational study

Key points

1. 01Pain hypervigilance (PVAQ score) was the only psychological factor that independently predicted both pain severity and pain interference at 6 months after adjusting for baseline pain
2. 02The widely used Orebro Musculoskeletal Pain Questionnaire (OMPQ) predicted pain persistence but lost significance once initial pain severity was controlled, suggesting its effect partly reflects pain level rather than independent risk
3. 03Pain hypervigilance showed a dual pattern: positively linked to social support and activity, but also linked to catastrophizing and pain behaviors, suggesting it can either help or hinder recovery
4. 04Pain behaviors (Pain Behaviour Checklist) predicted pain interference at 6 months before baseline adjustment, indicating visible pain behaviors are also relevant in the subacute window
5. 05The authors suggest early attention-management interventions (such as CBT or Attention Bias Modification) targeting hypervigilance could reduce the risk of chronicity

How it was conducted

Design

Longitudinal observational study with 6-month follow-up

Participants

75 adults with subacute back pain (7-12 weeks duration), mean age 36.0 years (SD 13.24), 65% female

Setting

Outpatient clinic and pain clinics affiliated with Heidelberg University, Germany

Key measures

OMPQ, PVAQ (pain hypervigilance), Pain Behaviour Checklist, MPI (pain severity and interference outcomes), plus anxiety, depression, stress, fear of pain, and catastrophizing scales

Primary outcomes

MPI pain severity and MPI pain-related interference at 6-month follow-up

Analysis

Principal component analysis for dimensionality reduction, best-subsets regression, and multistage linear regression with and without baseline adjustment

What they found

• PVAQ independently predicted 6-month pain severity after adjusting for baseline pain (beta = 0.25, p = 0.017; B = 0.05, 95% CI [0.01, 0.08]); final model explained 25% of variance (R2 adj = 0.25, F(2,72) = 13.16, p < 0.0001)
• PVAQ independently predicted 6-month pain-related interference after adjusting for baseline interference (beta = 0.33, p = 0.002; B = 0.07, 95% CI [0.03, 0.12]); model explained 23% of variance (R2 adj = 0.23, F(2,72) = 11.94, p < 0.001)
• OMPQ predicted 6-month pain severity without baseline adjustment (beta = 0.21, p = 0.064 marginal) and pain interference (beta = 0.23, p = 0.039), but lost significance after controlling for baseline pain severity (p = 0.53) and approached only marginal significance for interference (p = 0.054)
• PVAQ correlated with 6-month pain severity (r = 0.34, p = 0.003) and pain interference (r = 0.37, p = 0.001) at follow-up
• Pain Behaviour Checklist correlated with 6-month pain interference (r = 0.34, p = 0.003) but did not survive multistage regression after baseline adjustment (beta = 0.18, p = 0.11 in unadjusted model)
• Best-subset model for pain severity included OMPQ and PVAQ (adjusted R2 = 0.13, Mallows Cp = 1.52); best model for interference included OMPQ, PBC, and PVAQ (adjusted R2 = 0.22, Mallows Cp = 1.48)

Limitations

• Small sample (n = 75), recruited under strict criteria; planned target was 200, limiting generalizability and power for subgroup analyses
• Gender imbalance (approximately 2:1 female to male) may limit applicability of findings to male patients
• No post-hoc correction for multiple comparisons was applied, increasing the risk of Type I errors in the exploratory correlation analyses
• Psychological and social variables only; personality traits, central sensitization, neuroimaging, and other biological factors were not included as predictors in this analysis

Why it matters

For patients

If you have had back pain for 7-12 weeks, how closely you focus on and monitor your pain may be an important sign of whether it will persist, and targeting that attention pattern through therapy could help prevent chronic pain.

For clinicians

Screening for pain hypervigilance with the PVAQ in the subacute window may add predictive value beyond the OMPQ alone, and high hypervigilance scores could guide referral for early psychological intervention such as CBT or attention bias modification.

For readers

This study identifies pain hypervigilance as a potentially modifiable predictor of chronic back pain during the critical subacute stage, adding specificity to existing risk-screening tools and pointing toward attention-focused interventions.